ELISA Kit for Hyaluronic Acid (HA)

Hyaluronan; Hyaluronate

Specificity

This assay has high sensitivity and excellent specificity for detection of Hyaluronic Acid (HA).
No significant cross-reactivity or interference between Hyaluronic Acid (HA) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of Hyaluronic Acid (HA) and the recovery rates were calculated by comparing the measured value to the expected amount of Hyaluronic Acid (HA) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 96-105 101
EDTA plasma(n=5) 80-93 85
heparin plasma(n=5) 92-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Hyaluronic Acid (HA) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Hyaluronic Acid (HA) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Hyaluronic Acid (HA) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 86-101% 95-104% 79-88% 84-98%
EDTA plasma(n=5) 79-97% 78-104% 87-105% 89-103%
heparin plasma(n=5) 96-105% 89-97% 94-105% 97-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Clinical Infectious Diseases Hemorrhagic Fever Caused by a Novel Bunyavirus in China: Pathogenesis and Correlates of Fatal Outcome OxfordJournals: source
Critical Care Medicine Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: Role of platelet-derived growth factor pathway* PubMed: 22713216
European Archives of Oto-Rhino-Laryngology Age effects on extracellular matrix production of vocal fold scar fibroblasts in rats Pubmed: 24077847
Journal of Voice Vocal Fold Fibroblast Response to Growth Factor Treatment is Age Dependent: Results From an In Vitro Study ScienceDirect: S0892199713002415
Gynecol Oncol. Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acid Pubmed:24995580
Laryngoscope. Establishing principles of macromolecular crowding for in vitro fibrosis research of the vocal fold lamina propria Pubmed:25545625
Life Sci Pituitary tumor transforming gene as a novel regulatory factor of liver fibrosis PubMed: 25936962
Nutr Cancer Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-5 Infected Patients in Egypt PubMed: 26492131
Journal of Clinical Gastroenterology and Hepatology Study of Some Serum Biochemical Markers of Liver Fibrosis in Patients with Chronic HCV ISSN 2575-7733
BMC Complementary and Alternative Medicine A putative Chondroprotective role for IL-1β and MPO in herbal treatment of experimental osteoarthritis pubmed:29166937
Experimental and Therapeutic Medicine Polycomb group proteins: Novel molecules associated with ultraviolet A-induced photoaging of human skin. pubmed:28962194
European Journal of Applied Physiology The effect of aerobic walking and lower body resistance exercise on serum COMP and hyaluronan, in both males and females Pubmed:29536174
European Food Research and Technology Evaluation of antifibrotic effects of coffee and cocoa extracts in rats with thioacetamide-induced fibrosis 10.1007:s00217-018-3119-z
BioMed Research International Juvenile Ovine Ex Vivo Larynges: Phonatory, Histologic, and Micro CT Based Anatomic Analyses
Advances in Medical Sciences Selected elements of extracellular matrix of the skin in diabetes and insulin resistance Pubmed: 31146169
Viruses Strain-Dependent Porcine Circovirus Type 2 (PCV2) Entry and Replication in T-Lymphoblasts Pubmed: 31480752
Physiology International Betulin attenuated liver damage by prevention of hepatic mitochondrial dysfunction in rats with alcoholic steatohepatitis Pubmed: 31619044
Journal of Clinical Medicine Damage-Associated Molecular Patterns and Th-Cell-Related Cytokines Released after Progressive Effort Pubmed: 32210109
Journal of Proteomics iTRAQ-based analysis for the identification of MARCH8 targets in human esophageal squamous cell carcinoma 33540066
Eur J Appl Physiol An exploratory study to investigate the association between age, physical activity, femoral trochlear cartilage thickness and biomarkers of tissue metabolism in?¡­ 33713200
J Cell Physiol Trimethylamine N‐oxide exacerbates acetaminophen‐induced liver injury by interfering with macrophage‐mediated liver regeneration 34459512
Experimental Cell Research Comparative studies on the effect of pig adipose-derived stem cells (pASCs) preconditioned with hypoxia or normoxia on skin wound healing in mice Pubmed:35718003
Biomedicine & Pharmacotherapy Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6/STAT3 signaling pathway Pubmed:35658240
Sensors and Actuators B: Chemical Novel multifunctional delivery system for chondrocytes and articular cartilage based on carbon quantum dots
Catalog No. Related products for research use of Pan-species (General) Organism species Applications (RESEARCH USE ONLY!)
CPA182Ge11 BSA Conjugated Hyaluronic Acid (HA) Immunogen; SDS-PAGE; WB.
CPA182Ge21 OVA Conjugated Hyaluronic Acid (HA) Immunogen; SDS-PAGE; WB.
PAA182Ge01 Polyclonal Antibody to Hyaluronic Acid (HA) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
PAA182Ge02 Polyclonal Antibody to Hyaluronic Acid (HA) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
LAA182Ge81 FITC-Linked Polyclonal Antibody to Hyaluronic Acid (HA) WB; IHC; ICC; IF.
LAA182Ge71 Biotin-Linked Polyclonal Antibody to Hyaluronic Acid (HA) WB; IHC; ICC.
MAA182Ge22 Monoclonal Antibody to Hyaluronic Acid (HA) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
MAA182Ge21 Monoclonal Antibody to Hyaluronic Acid (HA) ELISA, CLIA. / IHC-Fr, ICC, IP (predicted).
MEA182Ge Mini Samples ELISA Kit for Hyaluronic Acid (HA) Enzyme-linked immunosorbent assay for Antigen Detection.
CEA182Ge ELISA Kit for Hyaluronic Acid (HA) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA182Ge Multiplex Assay Kit for Hyaluronic Acid (HA) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA182Ge11 ELISA Kit DIY Materials for Hyaluronic Acid (HA) Main materials for "Do It (ELISA Kit) Yourself".